Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2012
11/13/2012US8309796 Chimeric PUFA polyketide synthase systems and uses thereof
11/13/2012US8309745 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity
11/13/2012US8309693 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/13/2012US8309609 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
11/13/2012US8309574 Nuclear transfer promoter for Rac protein and method of screening the same
11/13/2012US8309565 Phosphonate compounds
11/13/2012US8309352 Human cord blood as a source of neural tissue repair of the brain and spinal cord
11/13/2012US8309087 Treatment with anti-ErbB2 antibodies
11/13/2012CA2478414C Selective targeting of tumor vasculature using antibody molecules
11/13/2012CA2454587C Stable lyophilized pharmaceutical formulation of igg antibodies
11/13/2012CA2428473C Method for producing pectin hydrolysis products
11/08/2012WO2012151450A1 Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
11/08/2012WO2012151440A1 Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
11/08/2012WO2012150707A1 Low molecular weight compound which promotes induction of differentiation of stem cells into insulin-producing cells and method for inducing differentiation of stem cells into insulin-producing cells using low molecular weight compound
11/08/2012WO2012150676A1 Synthetic peptide capable of inducing expression of type-2 tnf receptor and use thereof
11/08/2012WO2012150245A1 Katp antagonists (glibenglamid) for use for promoting growth and/or treating hyperglycaemia of a premature infant
11/08/2012WO2012122865A3 Pharmaceutically acceptable salt of (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide, preparation method therefor, and medical use thereof
11/08/2012WO2012106058A3 Animal treatments
11/08/2012WO2012017119A3 Non -viral vectors for gene therapy
11/08/2012US20120284005 System and methods for optimized drug delivery and progression of diseased and normal cells
11/08/2012US20120283620 Treatment utilizing hydrophobic weak bases chemotherapeutic agents and illumination
11/08/2012US20120283461 Pasteurisation process for microbial cells and microbial oil
11/08/2012US20120283331 Anti-Inflammatory Quinic Acid Derivatives for Radioprotection/Radiomitigation
11/08/2012US20120283317 Methods and Compositions for Regulating RNA Import into Mitochondria
11/08/2012US20120283218 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
11/08/2012US20120283217 Modulators of amyloid-beta production
11/08/2012US20120283206 Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent.
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120282285 Masp isoforms as inhibitors of complement activation
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/07/2012EP2520575A1 1,3,4-oxadiazole-2-carboxamide compound
11/07/2012EP2520570A1 Aminopyridine compound
11/07/2012EP2520309A1 Compositions and methods for soft tissue augmentation
11/07/2012EP2520300A1 Pharmaceutical composition for oral administration
11/07/2012EP2520299A1 Solid pharmaceutical composition for oral administration
11/07/2012EP2520298A1 Pharmaceutical composition comprising sulfonylureas (glibenclamide) or meglitinides for use for treating hyperglycaemia or for promoting growth of a premature infant
11/07/2012EP2520291A1 Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease
11/07/2012EP2520289A1 Norethisterone-containing patch
11/07/2012EP2519250A1 Interferon analogs
11/07/2012EP2519237A1 Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
11/07/2012EP2519232A1 Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
11/07/2012EP2213737B1 Double-stranded oligonucleotides
11/07/2012DE20321906U1 Pramipexol-Dosierform zur einmal täglichen Verabreichung Pramipexole dosage for once daily administration
11/07/2012CN1911960B Chlamydia protein, gene sequence and uses thereof
11/07/2012CN1871240B Pyrrolopyrimidine thion derivatives
11/07/2012CN102770435A Pyrazolopyrimidine compounds and their use as PDE10 inhibitors
11/07/2012CN102770159A Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
11/07/2012CN102770136A Therapeutic agent (Y - 39983) for corneal endothelial dysfunction
11/07/2012CN102766654A Slow virus expression vector specially promoting high expression of liver cell CYP1A2 gene, and construction method and application thereof
11/07/2012CN102766630A 6-modified bicyclic nucleic acid analogs
11/07/2012CN102764242A Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
11/07/2012CN102283745B Capsule for protecting umbilical cord of neonate
11/07/2012CN102258698B Chinese medicinal composition for treating dizziness
11/07/2012CN102068701B Application of cleavable polyethylene glycol (PEG) lipid derivative in preparation
11/07/2012CN101980705B Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
11/07/2012CN101838241B Production method of cimetidine
11/07/2012CN101687886B Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
11/07/2012CN101687822B Di(arylamino)aryl compound
11/07/2012CN101434598B Preparation of cilostazol
11/07/2012CN101415422B Anti-cancer pharmaceutical composition
11/07/2012CN101357946B Cholesterol metabolic regulation protein and use thereof
11/07/2012CN101356971B Anti-fatigue anti-hypoxia health food composition
11/07/2012CN101166719B Bcrp/abcg2 inhibitor
11/06/2012US8304453 Composition comprising at least one alkanolamide to inhibit migration of langerhans cells and uses therof
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
11/06/2012US8303949 Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
11/06/2012CA2495685C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
11/06/2012CA2489208C Interleukin-6 suppressive agent
11/06/2012CA2393467C Chordin-like molecules and uses thereof
11/06/2012CA2305630C Soluble single-chain t-cell receptor proteins
11/01/2012WO2012147986A1 Stable pharmaceutical composition
11/01/2012WO2012147916A1 Amide compound and pharmaceutical application therefor
11/01/2012WO2012147890A1 Novel azole derivative
11/01/2012WO2012147861A1 Composition for inhibiting endoserine-1 production and composition for promoting cell proliferation
11/01/2012WO2012147842A1 Beautiful-skin-promoting agent and use thereof
11/01/2012WO2012147819A1 Biological function reviving agent
11/01/2012WO2012147765A1 Benzimidazole derivative having npy y5 receptor antagonist action
11/01/2012WO2012147764A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
11/01/2012WO2012147763A1 Oxazine derivative and bace 1 inhibitor containing same
11/01/2012WO2012147762A1 Pyridine derivative and bace-1 inhibitor containing same
11/01/2012WO2012147597A1 Camptocormia therapeutic agent
11/01/2012WO2012147518A1 Novel 3-hydroxyisothiazole 1-oxide derivative
11/01/2012WO2012147516A1 Cyclic amide derivative
11/01/2012WO2012147171A1 Biological function reviving agent
11/01/2012WO2012147003A1 Vitamin b1 for treatment of chronic fatigue
11/01/2012WO2012068406A3 Use of hematopoietic growth factor mimetics
11/01/2012WO2012066581A4 Novel conjugates for targeted drug delivery
11/01/2012US20120277315 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
11/01/2012US20120277291 Preventive for adhesion following abdominal surgery
11/01/2012US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
11/01/2012US20120277277 Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal
11/01/2012US20120277234 1,2,4-oxadiazole benzoic acids
11/01/2012US20120277180 Cofactors and Methods for Use for Individuals
11/01/2012US20120277179 Edible Energy Composition
11/01/2012US20120277158 Compositions and methods for the transport of therapeutic agents
11/01/2012US20120276229 Primary bile acid and secondary bile acid generation regulator
11/01/2012US20120276126 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/01/2012US20120276103 Vhh for application in tissue repair, organ regeneration, organ replacement and tissue engineering
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 1564